Economic evaluation of Zepatier for the management of HCV in the Italian scenario

Francesca Romana Rolli,Matteo Ruggeri,F. Kheiraoui,Carlo Drago,Michele Basile,C. Favaretti,Americo Cicchetti

Economic evaluation of Zepatier for the management of HCV in the Italian scenario

2018

Francesca Romana Rolli
Matteo Ruggeri
F. Kheiraoui
Carlo Drago
Michele Basile
C. Favaretti
Americo Cicchetti

Background Hepatitis C virus (HCV) is a major health issue worldwide. New generation of direct-active antiviral medications is an epoch-making turning point in the management of HCV infections.

Keywords:

Risk analysis (engineering)
Hepatitis C virus
Physical therapy
Cost-effectiveness analysis
Opportunity cost
Economic evaluation
Medicine
turning point
Intensive care medicine
Actuarial science

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations